[{"NetIncomeLoss_1_Q2_USD":-20000000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":1392100000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":234600000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":220400000.0,"DepreciationAndAmortization_2_Q2_USD":165800000.0,"InventoryGross_0_Q2_USD":305000000.0,"PreferredStockSharesOutstanding_0_Q2_shares":50000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":1682800000.0,"InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0_Q2_USD":17200000.0,"ContractWithCustomerAssetCreditLossExpense_1_Q2_USD":0.0,"ContractWithCustomerAssetCreditLossExpense_2_Q2_USD":0.0,"FinanceLeaseLiability_0_Q2_USD":900000.0,"Liabilities_0_Q2_USD":2928700000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":200900000.0,"OtherAssetsNoncurrent_0_Q2_USD":99500000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":33500000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":66900000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-13700000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q2_USD":23800000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":230600000.0,"DerivativeLiabilitiesCurrent_0_Q2_USD":7400000.0,"CommonStockSharesIssued_0_Q2_shares":234921002.0,"UnrecognizedTaxBenefits_0_Q2_USD":28100000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1200000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":2200000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":17034848.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":17034848.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":0.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":6000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-45600000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":138700000.0,"OtherNoncashIncomeExpense_2_Q2_USD":20400000.0,"LongTermDebt_0_Q2_USD":2324900000.0,"AssetsCurrent_0_Q2_USD":868900000.0,"InventoryRawMaterialsAndSupplies_0_Q2_USD":79600000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":1415200000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-4300000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-54900000.0,"InventoryFinishedGoods_0_Q2_USD":189100000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":270200000.0,"Assets_0_Q2_USD":3304200000.0,"IncreaseDecreaseInInventories_2_Q2_USD":85900000.0,"RestrictedCashEquivalentsNoncurrent_0_Q2_USD":10600000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":15100000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":18400000.0,"AccountsReceivableNetCurrent_0_Q2_USD":226400000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-3400000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-53400000.0,"UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_2_Q2_USD":13800000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":0.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-50300000.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":33200000.0,"RestructuringCosts_1_Q2_USD":1700000.0,"RestructuringCosts_2_Q2_USD":3000000.0,"OtherLongTermDebt_0_Q2_USD":3200000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":30400000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":59300000.0,"OtherOperatingIncomeExpenseNet_1_Q2_USD":-10500000.0,"OtherOperatingIncomeExpenseNet_2_Q2_USD":-17900000.0,"OtherShortTermBorrowings_0_Q2_USD":2100000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":1200000.0,"NumberOfReportableSegments_2_Q2_Segment":3.0,"CommonStockValue_0_Q2_USD":0.0,"Revenues_2_Q2_USD":999300000.0,"StockIssuedDuringPeriodValueOther_2_Q2_USD":100000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-50200000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":-3.052,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":-0.453,"ForeignCurrencyTransactionGainLossUnrealized_1_Q2_USD":-35800000.0,"ForeignCurrencyTransactionGainLossUnrealized_2_Q2_USD":-13800000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-1300000.0,"ContractWithCustomerAssetNet_0_Q2_USD":47300000.0,"OtherAssetsCurrent_0_Q2_USD":136600000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":83100000.0,"OtherComprehensiveIncomeLossBeforeTax_1_Q2_USD":6300000.0,"OtherComprehensiveIncomeLossBeforeTax_2_Q2_USD":13500000.0,"DebtAndCapitalLeaseObligations_0_Q2_USD":2295000000.0,"InterestPayableCurrent_0_Q2_USD":20000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-38600000.0,"PaymentOfFinancingAndStockIssuanceCosts_2_Q2_USD":6800000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":6500000.0,"Revenues_1_Q2_USD":492500000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":165800000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":13500000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":6300000.0,"ShareBasedCompensation_2_Q2_USD":14500000.0,"RepaymentsOfShortTermDebt_2_Q2_USD":79900000.0,"InventoryWorkInProcess_0_Q2_USD":36300000.0,"ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_0_Q2_USD":500000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":122800000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":1100000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-7700000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":11000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":14500000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-4900000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-40700000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q2_USD":2229400000.0,"Goodwill_0_Q2_USD":578400000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":48500000.0,"AmortizationOfFinancingCosts_1_Q2_USD":1600000.0,"AmortizationOfFinancingCosts_2_Q2_USD":3300000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":26800000.0,"CommonStockSharesOutstanding_0_Q2_shares":234921002.0,"LiabilitiesCurrent_0_Q2_USD":479100000.0,"DeferredRevenueCurrent_0_Q2_USD":36600000.0,"AccountsPayableCurrent_0_Q2_USD":146400000.0,"InterestExpense_2_Q2_USD":76400000.0,"NetIncomeLoss_2_Q2_USD":-59100000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":799500000.0,"PreferredStockSharesIssued_0_Q2_shares":50000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":81500000.0,"RevenueNotFromContractWithCustomer_1_Q2_USD":5500000.0,"RevenueNotFromContractWithCustomer_2_Q2_USD":12600000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":62800000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":211500000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-89200000.0,"AdditionalPaidInCapital_0_Q2_USD":2407000000.0,"GrossProfit_1_Q2_USD":244400000.0,"GrossProfit_2_Q2_USD":503000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":950700000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":2200000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":66100000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":2200000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-1000000.0,"InterestExpense_1_Q2_USD":33000000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":400000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":67300000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1976600000.0,"DebtCurrent_0_Q2_USD":65600000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_1_Q2_USD":1100000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_2_Q2_USD":-7700000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-4900000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-40700000.0,"OperatingIncomeLoss_1_Q2_USD":31300000.0,"OperatingIncomeLoss_2_Q2_USD":88800000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":487000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":986700000.0,"InventoryNet_0_Q2_USD":305000000.0,"CommonStockSharesAuthorized_0_Q2_shares":1000000000.0,"OtherComprehensiveIncomeLossTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeLossTax_2_Q2_USD":0.0,"DeferredFinanceCostsNet_0_Q2_USD":23900000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":7300000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":1.39,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":63200000.0,"ShareBasedCompensation_1_Q2_USD":11000000.0,"AccrualForTaxesOtherThanIncomeTaxesCurrent_0_Q2_USD":15700000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1_Q2_USD":248100000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":1426400000.0,"PreferredStockValue_0_Q2_USD":100000.0,"PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0_Q2_USD":39600000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":4400000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":9700000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":19600000.0,"StockholdersEquity_0_Q2_USD":375600000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":99000000.0,"ProfitLoss_2_Q2_USD":-59100000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.09,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":36600000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.27,"AmortizationOfDebtDiscountPremium_1_Q2_USD":300000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":700000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":11000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":14500000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":62600000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":83200000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":3304200000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":14600000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":11000000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_2_Q2_USD":496300000.0,"Ticker":"OCDX","CIK":"1828443","name":"ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC","OfficialName":"Ortho Clinical Diagnostics Holdings plc Ordinary Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4468314033.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]